1. Moroz C, Giler SH, Kupfer B, Urca I: Lymphocytes bearing surface ferritin in patients with Hodgkin's disease and breast cancer. N Engl J Med 298: 1175–1176, 1977
2. Moroz C, Bessler H: Ferritin as a marker in malignancy. In: De Sousa M, Brock J (eds) Iron in Immunity, Cancer and Inflammation. Wiley, New York, 1989, pp 283–301
3. Maymon R, Bahari C, Moroz C: Placental isoferritin measured by a specific monoclonal antibody as a new predictive marker for premature contractions. Obstet Gynecol 74: 597–599, 1989
4. Hahn HWL, Stahlhut MW, Chung L: Inhibitory effects of isoferritins from tumour and non-tumour tissue on E-rosettes formation. Lancet i: 43–44, 1984
5. Rosen HR, Stierer M, Göttlicher J, Wolf H, Weber R, Vogl E, Eibl M: Determination of placental ferritin (PLF)-positive lymphocytes in women in early stages of breast cancer. Int J Cancer 52: 229–233, 1992